DMAA
Income statement / Annual
Last year (2025), Drugs Made In America Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Drugs Made In America Acquisition Corp.'s net income was $5.94 M.
See Drugs Made In America Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
| Period Ended |
12/31/2025 |
12/31/2024 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$2.82 M
|
$479.73
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.82 M
|
$479.73
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$2.82 M
|
$479.73
|
| Cost And Expenses |
$2.82 M
|
$479.73
|
| Interest Income |
$8.76 M
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$479.73
|
| EBITDA |
-$2.82 M |
$0.00 |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$8.76 M
|
$0.00
|
| Income Before Tax |
$5.94 M
|
-$479.00
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
| Net Income |
$5.94 M
|
-$479.00
|
| Net Income Ratio |
0
|
0
|
| EPS |
0.19 |
-0.056 |
| EPS Diluted |
0.19 |
-0.056 |
| Weighted Average Shares Out |
$21.01 M
|
$8.57 M
|
| Weighted Average Shares Out Diluted |
$21.01 M
|
$8.57 M
|
| Link |
|
|
